| ObsEva SA - Common Shares (NQ:OBSV)All News about ObsEva SA - Common Shares      
    ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
     November 22, 2022 From ObsEva SA Via GlobeNewswire         
    ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
     October 26, 2022 From ObsEva SA Via GlobeNewswire         Via Benzinga       
    After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
     September 13, 2022 Via Benzinga         Via Benzinga     
    Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
     September 01, 2022 Via Benzinga                     Via Benzinga 
   Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service. 
  © 2025 FinancialContent. All rights reserved.
  |  | 
| ObsEva SA - Common Shares (NQ:OBSV)All News about ObsEva SA - Common Shares
   Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service. 
  © 2025 FinancialContent. All rights reserved.
  |  | 
